Antidote
|
Indication
|
Mode of Action
|
acetylcysteine (Mucomyst)
|
Acetaminophen/ Tylenol/ Paracetamol
|
Restores depleted glutathione stores and protects against renal and hepatic failure.
|
Activated charcoal
|
Non-specific poisons except cyanide, iron, lithium, caustics and alcohol.
|
Absorption of drug in the gastric and intestinal tracts. Interrupts the entero-hepatic cycle with multiple dose.
|
albuterol inhaler, insulin & glucose, NaHCO3, kayexalate
|
Potassium
|
|
anticholinesterase agents
|
Neuromuscular blockade (paralytics)
|
|
atropine sulfate or pralidoxime
|
Anticholinesterase
|
Competitive inhibition of muscarinic receptors.
|
Benzylpenicillin
|
Amanita phalloides (Death cap mushroom)
|
Not known; partial protection against acute hepatic failure; may displace amatoxin from protein-binding sites allowing increased renal excretion; may also inhibit penetration of amatoxin to hepatocytes.
|
Calcium salts
|
Fluoride ingestion
|
Rapidly complexes with fluoride ion.
|
deferoxamine
|
Iron
|
Deferoxamine acts by binding free iron in the bloodstream and enhancing its elimination in the urine.
|
digibind
digoxine immune fab
|
Digoxin
|
Binds molecules of digoxin, making them unavailable for binding at their site of action on cells in the body.
|
dimercapol, edetate calcium, disodium,
|
Lead
|
Chelation of lead ions and endogenous metals (e.g., zinc, manganese, iron, copper).
|
diphenhydramine (Benadryl)
|
Extrapyramidal symptoms (EPS)
|
A potent antagonist to acetylcholine in muscarinic receptors.
|
flumazenil
|
Benzodiazepines
|
Reverses the effects of benzodiazepines by competitive inhibition at the benzodiazepine binding site on the GABAA receptor.
|
fomepizole
|
Ethylene glycol
|
A competitive inhibitor of the enzyme alcohol dehydrogenase found in the liver. This enzyme plays a key role in the metabolism of ethylene glycol and methanol.
|
glucagon
|
Beta blockers and calcium channel blockers
|
Stimulates the formation of adenyl cyclase causing intracellular increase in cycling AMP and enhanced glycogenolysis and elevated serum glucose concentration.
|
Glucose (Dextrose 50%)
|
Insulin reaction
|
Dextrose (the monosaccharide glucose) is used, distributed and stored by body tissues and is metabolized to carbon dioxide and water with the release of energy.
|
Heparin
|
Ergotamine
|
Reverses hypercoagulable state by interacting with antithrombin III. Used in combination with vasodilator phentolamine or nitroprusside to prevent local thrombosis and ischemia.
|
Hydroxocobalamin
|
Cyanide
|
Forms cyanocobalamin, a non-toxic metabolite that is easily excreted through the kidneys.
|
leucovorin calcium
|
Fluorouracil
|
|
Methotrexate
|
Protects the healthy cells from the effects of methotrexate while allowing methotrexate to enter and kill cancer cells.
|
Magnesium sulfate
|
calcium gluconate
|
|
mesna
|
Cyclophosphamide
|
A “chemoprotectant” drug that reduces the undesired effects of certain chemotherapy drugs.
|
Methylene blue
|
Chemical producing severe methemoglobinemia. Ifosamide-induced encephalopathy.
|
Reduces methemoglobin to hemoglobin.
|
nalmefene or naloxone
|
Opioid analgesics
|
Prevents or reverses the effects of opioids including respiratory depression, sedation and hypotension.
|
naloxone (Narcan)
|
Narcotics
|
Naloxone is believed to antagonize opioid effects by competing for the µ, ? and ? opiate receptor sites in the CNS, with the greatest affinity for the µ receptor.
|
Neostigmine
|
Anticholinergics
|
Anticholinesterase which causes accumulation of acetylcholine at cholinergic receptor sites.
|
Nitrite, sodium and glycerytrinitrate
|
Cyanide
|
Oxidizes hemoglobin to methemoglobin which binds the free cyanide and can enhance endothelial cyanide detoxification by producing vasodilation.
|
Penicillamine
|
Copper, gold, lead, mercury, zinc, arsenic
|
Chelation of metal ions.
|
phentolamine (Regitine)
|
Dopamine
|
Regitine produces an alpha-adrenergic block of relatively short duration. It also has direct, but less marked, positive inotropic and chronotropic effects on cardiac muscle and vasodilator effects on vascular smooth muscle.
|
phyostigmine or NaHCO3
|
Tricyclic antidepressants
|
A reversible anticholinesterase which effectively increases the concentration of acetylcholine at the sites of cholinergic transmission.
|
Phytomenadione (Vitamin K.)
|
Coumadin/Warfarin
|
Bypasses inhibition of Vitamin K epoxide reductase enzyme.
|
protamine sulfate
|
Heparin
|
Protamine that is strongly basic combines with acidic heparin forming a stable complex and neutralizes the anticoagulant activity of both drugs.
|
Pyridoxine
|
Isoniazid, theophylline, monomethyl hydrazine. Adjunctive therapy in ethylene glycol poisoning.
|
Reverses acute pyridoxine deficiency by promoting GABA synthesis. Promotes the conversion of toxic metabolite glycolic acid to glycine.
|
Snake anti-venin
|
Cobra bite
|
Neutralizes venom by binding with circulating venom components and with locally deposited venom by accumulating at the bite site.
|
Sodium Bicarbonate
|
Iron
|
Prevents convertion of ferrous to ferric.
|
Cardiotoxic drug affecting fast sodium channel (TCA, cocaine)
|
Decreases affinity of cardiotoxic drugs to the fast sodium channel.
|
Weak acids
|
Promotes ionization of weak acids.
|
Chlorine gas inhalational poisoning
|
Neutralization of hydrochloric acid formed when chlorine gas reacts with water in the airways.
|
Sodium thiosulphate
|
Cyanide
|
Replenishes depleted thiosulphate stores by acting as sulfur donor necessary for the conversion of CN-O to thiocyanate through the action of sulfur transferase enzyme rhodanese.
|
Thiamine
|
Alcohol, Wernicke-Korsakoff Syndrome
|
Reverses acute thiamine deficiency
|
Adjunctive in ethylene glycol
|
Enhances detoxification of glyoxylic acid.
|
Vitamin C
|
Chemicals causing methemoglobinemia in patients with G6PD deficiency
|
Reduces methemoglobin to hemoglobin.
|